Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Adeno-associated virus (AAV) Rep78 protein is a multifunctional non-structural protein that serves as the primary orchestrator of the AAV life cycle. It forms complex interactions with both viral DNA and a variety of host cellular replication factors, such as Proliferating Cell Nuclear Antigen (PCNA), Replication Protein A (RPA), and the Minichromosome Maintenance (MCM) complex. These interactions allow Rep78 to perform essential tasks including site-specific endonuclease cleavage at the terminal resolution site, ATP-dependent DNA unwinding, and the recruitment of cellular polymerases for viral genome synthesis. Beyond its role in replication, Rep78 is a potent regulator of gene expression and can induce cell cycle arrest in the S-phase, which has led to research into its potential anti-tumor properties. In the field of biotechnology, Rep78 is a critical component in the production of AAV vectors for gene therapy, where its ability to mediate site-specific integration into the human chromosome 19 (AAVS1 locus) is of significant interest for stable transgene expression. However, its inherent cytotoxicity and complex regulatory effects on host cell machinery present ongoing challenges in optimizing its use for therapeutic applications.
Rep78 functions as a site-specific endonuclease and ATP-dependent helicase that binds to the inverted terminal repeats (ITRs) of the AAV genome and the cellular AAVS1 integration site. It recruits host cellular replication machinery, including PCNA, RPA, and DNA polymerase delta, to facilitate viral genome synthesis while simultaneously inhibiting host cell division by interfering with the MCM complex and other cell cycle regulators.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adeno-associated virus Rep78-replication factor complex (Rep78 complex).